AMERICAN SHARED HOSPITAL SERVICES Cash and Cash Equivalents
AMERICAN SHARED HOSPITAL SERVICES (AMS) had Cash and Cash Equivalents of $6.51 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-13
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $6.51M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $4.97M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $3.46M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $5.09M.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2026-06-30 | $6.51M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $4.97M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $3.46M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $5.09M 10-Q/A · filed 2026-01-16 |
| 2025-06-30 | $11.08M 10-Q · filed 2026-08-13 |
| 2025-03-31 | $11.24M 10-Q · filed 2026-05-14 |
| 2024-12-31 | $11.03M 10-K · filed 2026-03-31 |
| 2024-09-30 | $13.83M 10-Q/A · filed 2026-01-16 |
| 2024-06-30 | $14.24M 10-Q · filed 2025-08-13 |
| 2024-03-31 | $12.79M 10-Q · filed 2025-05-15 |
| 2023-12-31 | $13.69M 10-K · filed 2025-04-04 |
| 2023-09-30 | $14.54M 10-Q · filed 2024-11-14 |
| 2023-06-30 | $13.68M 10-Q · filed 2024-08-14 |
| 2023-03-31 | $13.08M 10-Q · filed 2024-05-15 |
| 2022-12-31 | $12.34M 10-K · filed 2024-04-01 |
| 2022-09-30 | $11.55M 10-Q · filed 2023-11-14 |
| 2022-06-30 | $11.85M 10-Q · filed 2023-08-14 |
| 2022-03-31 | $8.28M 10-Q · filed 2023-05-12 |
| 2021-12-31 | $8.14M 10-K · filed 2023-03-31 |
| 2021-09-30 | $7.05M 10-Q · filed 2022-11-10 |
| 2021-06-30 | $8.32M 10-Q · filed 2022-08-15 |
| 2021-03-31 | $4.89M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $3.96M 10-K · filed 2022-03-30 |
| 2020-09-30 | $3.62M 10-Q · filed 2020-11-13 |
| 2020-06-30 | $4.04M 10-Q · filed 2020-08-14 |
| 2020-03-31 | $2.67M 10-Q/A · filed 2020-06-11 |
| 2019-12-31 | $1.43M 10-K · filed 2021-04-06 |
| 2019-09-30 | $1.30M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $1.91M 10-Q · filed 2019-08-13 |
| 2019-03-31 | $2.05M 10-Q · filed 2019-05-13 |
| 2018-12-31 | $1.44M 10-K · filed 2020-04-03 |
| 2018-09-30 | $1.84M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $3.49M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $2.75M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $2.15M 10-K · filed 2019-03-29 |
| 2017-09-30 | $1.31M 10-Q · filed 2017-11-13 |
| 2017-06-30 | $2.60M 10-Q · filed 2017-08-10 |
| 2017-03-31 | $2.40M 10-Q · filed 2017-05-15 |
| 2016-12-31 | $2.87M 10-K · filed 2018-03-28 |
| 2016-09-30 | $1.85M 10-Q · filed 2017-11-13 |
| 2016-06-30 | $1.76M 10-Q · filed 2017-08-10 |
| 2016-03-31 | $2.14M 10-Q · filed 2017-05-15 |
| 2015-12-31 | $2.21M 10-K · filed 2018-03-28 |
| 2015-09-30 | $2.18M 10-Q · filed 2016-11-10 |
| 2015-06-30 | $1.80M 10-Q · filed 2016-08-11 |
| 2015-03-31 | $927.00K 10-Q · filed 2016-05-12 |
| 2014-12-31 | $1.06M 10-K · filed 2018-03-28 |
| 2014-09-30 | $1.42M 10-Q · filed 2015-11-12 |
| 2014-06-30 | $944.00K 10-Q · filed 2015-08-19 |
| 2014-03-31 | $957.00K 10-Q · filed 2015-05-14 |
| 2013-12-31 | $1.91M 10-K · filed 2017-03-27 |
| 2013-09-30 | $1.96M 10-Q · filed 2014-11-14 |
| 2013-06-30 | $1.34M 10-Q · filed 2014-08-15 |
| 2012-12-31 | $1.56M 10-K · filed 2016-03-30 |
| 2011-12-31 | $2.58M 10-K · filed 2015-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |